P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage
Anna Luisa Di Stefano(Hôpital Foch), Marc Sanson(Centre National de la Recherche Scientifique), Marine Giry(Centre National de la Recherche Scientifique), Chiara Villa(Centre National de la Recherche Scientifique), Chris Ottolenghi(Hôpital Necker-Enfants Malades), Francesca Branzoli(Centre National de la Recherche Scientifique), Karima Mokhtari(Inserm), Stéphane Lehéricy(Centre National de la Recherche Scientifique), L. Capelle(Sorbonne Université), Małgorzata Marjańska(University of Minnesota)
Cited by 0
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
Contributions of the basal ganglia and functionally related brain structures to motor learning
|Behavioural Brain Research|2008|776
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772